Agreement between self-report and prescription data in medical records for pregnant women

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 94, Issue 3, 2012, Pages 153-161

  Sarangarm, Preeyaporn ^a   Young, Bonnie ^b   Rayburn, William ^c   Jaiswal, Pallavi ^b   Dodd, Melanie ^b   Phelan, Sharon ^c   Bakhireva, Ludmila ^b  

^a UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Information bias; Medications; Pregnancy; Self report; Validity

Indexed keywords

AMFEBUTAMONE; ANTIBIOTIC AGENT; ATENOLOL; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; CALCIUM CHANNEL BLOCKING AGENT; CEPHALOSPORIN; CODEINE; CORTICOSTEROID; FLUCONAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCODONE; INSULIN; ISOMETHEPTENE MUCATE; LABETALOL; LEVOTHYROXINE; METOPROLOL; METRONIDAZOLE; NITROFURANTOIN; NORTRIPTYLINE; OXYCODONE; PENICILLIN G; PROPRANOLOL; PROTON PUMP INHIBITOR; SALBUTAMOL; SULFONYLUREA; SUMATRIPTAN;

ADULT; ARTICLE; EDUCATIONAL STATUS; ELECTRONIC MEDICAL RECORD; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; MENSTRUAL CYCLE; PATIENT CARE; PREGNANT WOMAN; PRENATAL CARE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SEMI STRUCTURED INTERVIEW; SENSITIVITY AND SPECIFICITY;

ADULT; AMBULATORY CARE FACILITIES; ANTI-BACTERIAL AGENTS; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPOGLYCEMIC AGENTS; INTERVIEWS AS TOPIC; NEW MEXICO; PREGNANCY; PRENATAL CARE; PRESCRIPTION DRUGS; RECORDS AS TOPIC; REPRODUCIBILITY OF RESULTS; SELF REPORT; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84858180763     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.22888     Document Type: Article

References (64)

1. Altman DG. 1991. Practical statistics for medical research. London: Chapman and Hall.
2. Andrade SE, Gurwitz JH, Davis RL, et al. 2004. Prescription drug use in pregnancy. Am J Obstet Gynecol 191: 398-407.
3. Bakhireva LN, Jones KL, Schatz M, et al. 2005. Asthma medication use in pregnancy and fetal growth. J Allergy Clin Immunol 116: 503-509.
4. Bakhireva LN, Jones KL, Schatz M, et al. 2007. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol 119: 618-625.
5. Bakhireva LN, Young BN, Dalen J, et al. 2009. Periconceptional binge drinking and acculturation among pregnant Latinas in New Mexico. Alcohol 43: 475-481.
6. Beardon PH, McGilchrist MM, McKendrick AD, et al. 1993. Primary non-compliance with prescribed medication in primary care. BMJ 307: 846-848.
7. Borgsdorf LR, Cada DJ, Cirigliano MD, et al. editors. 2008. Drug facts and comparisons. St. Louis: Wolters Kluwer Health.
8. Briggs GG, Freeman RK, Yaffe SJ. 2008. Drugs in pregnancy and lactation. 8th ed. Philadelphia: Lippincott Williams and Wilkins.
9. Broussard CS, Rasmussen SA, Reefhuis J, et al. 2011. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 204: 314.e31-314.e311.
10. Brown DW, Anda RF, Felitti VJ. 2007. Self-reported information and pharmacy claims were comparable for lipid-lowering medication exposure. J Clin Epidemiol 60: 525-529.
11. Bryant HE, Visser N, Love EJ. 1989. Records, recall loss, and recall bias in pregnancy: a comparison of interview and medical records data of pregnant and postnatal women. Am J Public Health 79: 78-80.
12. Caskie GI, Willis SL. 2004. Congruence of self-reported medications with pharmacy prescription records in low-income older adults. Gerontologist 44: 176-185.
13. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. 2006. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354: 579-587.
14. Chambers CD, Johnson DL, Robinson LK, et al. 2010. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum 62: 1494-1503.
15. Colvin L, Slack-Smith L, Stanley FJ, Bower C. 2010. Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens. Pharmacoepidemiol Drug Saf 19: 1137-1150.
16. Curtis JR, Westfall AO, Allison J, et al. 2006. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiol Drug Saf 15: 710-718.
17. DiMatteo MR. 2004. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42: 200-209.
18. Espnes MG, Bjørge T, Engeland A. 2011. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 20: 243-248.
19. Felix RJ, Jones KL, Johnson KA, et al. 2004. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project. Birth Defects Res A Clin Mol Teratol 70: 944-947.
20. Fischer MA, Stedman MR, Lii J, et al. 2010. Primary medication non-adherence: analysis of 195, 930 electronic prescriptions. J Gen Intern Med 25: 284-290.
21. Fonager K, Larsen H, Pedersen L, Sørensen HT. 2000. Birth outcomes in women exposed to anticonvulsant drugs. Acta Neurol Scand 101: 289-294.
22. Fosnocht DE, Swanson ER, Barton ED. 2005. Changing attitudes about pain and pain control in emergency medicine. Emerg Med Clin North Am 23: 297-306.
23. Gentile S, Bellantuono C. 2009. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. J Clin Psychiatry 70: 414-422.
24. Glintborg B, Hillestrøm PR, Olsen LH, et al. 2007. Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients. J Clin Pharmacol 47: 1440-1449.
25. Glover DD, Amonkar M, Rybeck BF, Tracy TS. 2003. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 188: 1039-1045.
26. Haapea M, Miettunen J, Lindeman S, et al. 2010. Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 Birth Cohort. Int J Methods Psychiatr Res 19: 88-96.
27. Handal M, Engeland A, Rønning M, et al. 2011. Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. Eur J Clin Pharmacol 67: 953-960.
28. Irl C, Hasford J. 2000. Assessing the safety of drugs in pregnancy: the role of prospective cohort studies. Drug Saf 22: 169-177.
29. Kelly JP, Rosenberg L, Kaufman DW, Shapiro S. 1990. Reliability of personal interview data in a hospital-based case-control study. Am J Epidemiol 131: 79-90.
30. Kluger BM, Meador KJ. 2008. Teratogenicity of antiepileptic medications. Semin Neurol 28: 328-335.
31. Koren G, Levichek Z. 2002. The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk. Am J Obstet Gynecol 186( 5 Suppl Understanding): S248-252.
32. Kropp S, Terboven T, Hedicke J, et al. 2007. Good agreement between physician and self-reported hormone therapy data in a case-control study. J Clin Epidemiol 60: 1280-1287.
33. Kulaga S, Zargarzadeh AH, Bérard A. 2009. Prescriptions filled during pregnancy for drugs with the potential of fetal harm. BJOG 116: 1788-1795.
34. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL. 2000. Prescription of drugs during pregnancy in France. Lancet 356: 1735-1736.
35. Landis JR, Koch GG. 1977. The measurement of observer agreement for categorical data. Biometrics 33: 159-174.
36. Løkkegaard EL, Johnsen S, Heitmann BL, et al. 2004. The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand 83: 476-481.
37. McHorney CA, Victor Spain C, Alexander CM, Simmons J. 2009. Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims. Clin Ther 31: 2584-2607.
38. Melamed N, Yogev Y. 2009. Can pregnant diabetics be treated with glyburide? Womens Health (Lond Engl) 5: 649-658.
39. Mitchell AA, Cottler LB, Shapiro S. 1986. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 123: 670-676.
40. Mitchell AA, Gilboa SM, Werler MM, et al. 2011. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 205:51.e1-51.e8.
41. Mukerji SS, Duffy SA, Fowler KE, et al. 2007. Comorbidities in head and neck cancer: agreement between self-report and chart review. Otolaryngol Head Neck Surg 136: 536-542.
42. Nakhai-Pour HR, Rey E, Bérard A. 2010. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol 89: 147-154.
43. Nielsen MW, Søndergaard B, Kjøller M, Hansen EH. 2008. Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. J Clin Epidemiol 61: 919-924.
44. Noize P, Bazin F, Dufouil C, et al. 2009. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf 18: 310-319.
45. Okura Y, Urban LH, Mahoney DW, et al. 2004. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57: 1096-1103.
46. Olesen C, Søndergaard C, Thrane N, et al. 2001. Do pregnant women report use of dispensed medications? Epidemiology 12: 497-501.
47. Persell SD, Osborn CY, Richard R, et al. 2007. Limited health literacy is a barrier to medication reconciliation in ambulatory care. J Gen Intern Med 22: 1523-1526.
48. Petersen EE, Rasmussen SA, Daniel KL, et al. 2008. Prescription medication borrowing and sharing among women of reproductive age. JWomens Health (Larchmt) 17: 1073-1080.
49. Riley EH, Fuentes-Afflick E, Jackson RA, et al. 2005. Correlates of prescription drug use during pregnancy. J Womens Health (Larchmt) 14: 401-409.
50. Rockenbauer M, Olsen J, Czeizel AE, et al. 2001. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology 12: 461-466.
51. Sandini L, Pentti K, Tuppurainen M, et al. 2008. Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study. Menopause 15: 282-289.
52. Schneeweiss S, Avorn J. 2005. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 58: 323-337.
53. Sjahid SI, van der Linden PD, Stricker BH. 1998. Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study. Br J Clin Pharmacol 45: 591-595.
54. Solomon DH, Stedman M, Licari A, et al. 2007. Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries. Arthritis Rheum 57: 234-239.
55. Spencer AL, Bonnema R, McNamara MC. 2009. Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications. Am J Med 122: 497-506.
56. Szklo M, Nieto J. 2007. Epidemiology: beyond the basics. 2nd ed. Boston: Jones and Bartlett Publishers.
57. Tisnado DM, Adams JL, Liu H, et al. 2006. What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care 44: 132-140.
58. Toh S, Mitchell AA, Louik C, et al. 2009. Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction. J Clin Psychopharmacol 29: 555-560.
59. Tomson T, Battino D. 2009. Teratogenic effects of antiepileptic medications. Neurol Clin 27: 993-1002.
60. Vallerand A, Nowak L. 2010. Chronic opioid therapy for nonmalignant pain: the patient's perspective. Part II-Barriers to chronic opioid therapy. Pain Manag Nurs 11: 126-131.
61. Van den Brandt PA, Petri H, Dorant E, et al. 1991. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci 13: 91-96.
62. West SL, Savitz DA, Koch G, et al. 1995. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 142: 1103-1112.
63. West SL, Savitz DA, Koch G, et al. 1997. Demographics, health behaviors, and past drug use as predictors of recall accuracy for previous prescription medication use. J Clin Epidemiol 50: 975-980.
64. Westbrook JI, McIntosh JH, Rushworth RL, et al. 1998. Agreement between medical record data and patients' accounts of their medical history and treatment for dyspepsia. J Clin Epidemiol 51: 237-244.